Drugs / YH14617
last change Feb 2015 re-read 3 minutes ago

YH14617

Developed for
diabetes mellitus
Investigated by
Peptron, Inc. · Yuhan Corporation

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01507038 Dec 2011 → Jan 2015 diabetes mellitus Yuhan Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as YH14617 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01507038 ↗